Eddie Hickman

Stock Analyst at Guggenheim

(3.80)

# 219

Out of 4,414 analysts

6

Total ratings

83.33%

Success rate

47.46%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	OTLK Outlook Therapeutics	Upgrades: Buy	$40	$8.50	+370.59%	2	Jan 25, 2024
	TARS Tarsus Pharmaceuticals	Maintains: Buy	$46 → $49	$34.63	+41.50%	4	Sep 11, 2023

Outlook Therapeutics

Jan 25, 2024

Upgrades: Buy

Price Target: $40

Current: $8.50

Upside: +370.59%

Tarsus Pharmaceuticals

Sep 11, 2023

Maintains: Buy

Price Target: $46 → $49

Current: $34.63

Upside: +41.50%